No thyroid mdicines seem to have gone through the processes yet. Nor am I clear exactly what happens when a product has been approved. Can the compnay immediately sell it everywhere? Will Patient Information Leaflets be posted on EMC?
Have we got anyone familiar with the interpretation of EU documents? They are daunting.
Written by
helvella
Administrator
To view profiles and participate in discussions please or .
The paper you refer to does say"The centralised procedure is compulsory for:
human medicines for the treatment of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), cancer, diabetes, neurodegenerative diseases, AUTO-IMMUNE AND OTHER IMMUNE DUSFUNCTIONS, and viral diseases;"
This might include Hashimoto thyroid. Maybe Sanofi Aventis should apply for approval of CYNOMEL in the UK?
Yes - I saw that and took it to refer to the medicines that are used such as:
Many people take medicines to reduce the immune system's abnormal response. These are often called immunosuppressive medicines. Examples include corticosteroids (such as prednisone) and nonsteroid drugs such as azathioprine, cyclophosphamide, mycophenolate, sirolimus, or tacrolimus.
My thought being that they are directed at the disfunctions whereas thyroid hormone is simply replacing what isn't there without being specific to auotimmune disorders. I'd be happy to see that I am wrong!
Quite a number of medicines seem to be in process - for example, amitriptyline - but either they are still in porcess, or it has had little effect yet in the UK.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.